Balyasny Asset Management LLC Medtronic PLC Call Options Transaction History

Balyasny Asset Management LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.84 - $91.03 $4.13 Million - $4.9 Million	53,800 New	53,800 $4.84 Million
Q1 2024 May 13, 2024	BUY	$82.84 - $88.09 $6.75 Million - $7.18 Million	81,500 Added 1273.44%	87,900 $7.66 Million
Q4 2023 Feb 14, 2024	BUY	$69.43 - $83.43 $444,352 - $533,952	6,400 New	6,400 $527,000
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $761,050 - $838,053	-6,200 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$118.19 - $131.5 $5.18 Million - $5.76 Million	-43,800 Reduced 87.6%	6,200 $770,000
Q4 2020 Feb 16, 2021	SELL	$100.57 - $117.14 $10.1 Million - $11.7 Million	-100,000 Reduced 66.67%	50,000 $5.86 Million
Q3 2020 Nov 16, 2020	SELL	$90.13 - $108.78 $18 Million - $21.8 Million	-200,000 Reduced 57.14%	150,000 $15.6 Million
Q1 2018 May 15, 2018	BUY	$76.55 - $87.26 $2.3 Million - $2.62 Million	30,000 Added 9.38%	350,000 $28.1 Million
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $24.6 Million - $26.7 Million	320,000	320,000 $25.8 Million

2,287

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $114B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.